Propolis - Gehrlicher Pharmazeutische Extrakte

Drug Profile

Propolis - Gehrlicher Pharmazeutische Extrakte

Alternative Names: GH 2002; Propolis extract; Propolis special extract

Latest Information Update: 05 Apr 2016

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Gehrlicher Pharmazeutische Extrakte
  • Class Anti-inflammatories; Antiacnes; Antiasthmatics; Antibacterials; Antipsoriatics; Antivirals
  • Mechanism of Action Lipoxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Clinical Phase Unknown Herpes zoster

Most Recent Events

  • 15 Dec 2016 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top